Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Molecular Profile | Unknown unknown |
Therapy | Carboplatin + Paclitaxel + Panobinostat |
Indication/Tumor Type | Advanced Solid Tumor |
Response Type | not applicable |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
Unknown unknown | Advanced Solid Tumor | not applicable | Carboplatin + Paclitaxel + Panobinostat | Phase I | Actionable | In a Phase I trial, 52% (11/21) of patients with advanced solid tumors demonstrated stable disease when treated with Farydak (panobinostat), in combination with Paraplatin (carboplatin) and Taxol (paclitaxel) (PMID: 22851205). | 22851205 |
PubMed Id | Reference Title | Details |
---|---|---|
(22851205) | A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors. | Full reference... |